Research Areas

Pharmacogenomic Biomarker Information in Drug Labels Approved by the United States Food and Drug Administration: Prevalence of Related Drug Use.

Comprehensive review of FDA drug labeling content regarding human genomic biomarker information. Also provides a retrospective analysis of the nationwide prevalence of use of medications that contain pharmacogenomic biomarker information in their respective drug labels.

Frueh F, et al.

Pharmacotherapy. 2008;28(8):992-998.

* By selecting this link, you will be leaving the Medco Research Institute website and linking to
another website which may be governed by a separate and different Terms of Use and Privacy Policy.

Medco, Making Medicine Smarter, Medco Research Institute and Medco Therapeutic Resource Centers are registered trademarks of Medco Health Solutions, Inc.
Advancing Smarter Medicine is a trademark of Medco Health Solutions, Inc.
Medco Research Institute®, LLC, is a wholly-owned subsidiary of Medco Health Solutions, Inc.